Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
暂无分享,去创建一个
Runzhi Huang | D. Song | T. Meng | Huabin Yin | Jie Zhang | Penghui Yan | P. Hu | Zongqiang Huang | Juanru Guo | Jiayao Zhang | Shuyuan Xian | Zhenyu Li | Jiwen Zhu | Mingxiang Fan | Chunling Long | Runping Xu | Jiayao Zhang
[1] C. Shao,et al. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells , 2021, Cells.
[2] O. Elemento,et al. Clinical features of neuroendocrine prostate cancer. , 2019, European journal of cancer.
[3] Mohammad Hossein Khosravi,et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 , 2019, JAMA oncology.
[4] Peihong Wu,et al. Alternative splicing events are prognostic in hepatocellular carcinoma , 2019, Aging.
[5] P. Barata,et al. Metastatic castration‐sensitive prostate cancer: Abiraterone, docetaxel, or… , 2019, Cancer.
[6] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[7] Jacob D. Jaffe,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.
[8] E. Thompson,et al. The phosphorylation status of PIP5K1C at serine 448 can be predictive for invasive ductal carcinoma of the breast , 2018, Oncotarget.
[9] N. Cho,et al. HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer , 2018, AntiCancer Research.
[10] E. Crawford,et al. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations , 2018, Prostate Cancer and Prostatic Diseases.
[11] Herng‐Ching Lin,et al. Alzheimer’s disease is associated with prostate cancer: a population-based study , 2018, Oncotarget.
[12] Jing Wang,et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types , 2017, Nucleic Acids Res..
[13] Rebeca D Martínez-Contreras,et al. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools , 2017, Genes.
[14] Adam Godzik,et al. The Functional Impact of Alternative Splicing in Cancer. , 2017, Cell reports.
[15] R. Aebersold,et al. Impact of Alternative Splicing on the Human Proteome , 2017, Cell Reports.
[16] Chad J. Creighton,et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.
[17] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[18] K. Nead,et al. Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis , 2017, Prostate Cancer and Prostatic Diseases.
[19] B. Cullen,et al. Update on Alzheimer's Disease Therapy and Prevention Strategies. , 2017, Annual review of medicine.
[20] A. Zoubeidi,et al. Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer , 2016, Scientific Reports.
[21] Charles G. Drake,et al. Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer , 2016, Oncotarget.
[22] Alzheimer’s Association,et al. 2016 Alzheimer's disease facts and figures , 2016, Alzheimer's & Dementia.
[23] L. Shkreta,et al. Defective control of pre–messenger RNA splicing in human disease , 2016, The Journal of cell biology.
[24] Robert Brown,et al. TCGASpliceSeq a compendium of alternative mRNA splicing in cancer , 2015, Nucleic Acids Res..
[25] F. Montorsi,et al. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer. , 2015, European urology.
[26] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[27] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[28] Caterina Marchiò,et al. SF3B1 mutations constitute a novel therapeutic target in breast cancer , 2014, The Journal of pathology.
[29] Qingwen Xu,et al. Targeting Type Iγ Phosphatidylinositol Phosphate Kinase Inhibits Breast Cancer Metastasis , 2014, Oncogene.
[30] Chirayu Pankaj Goswami,et al. PROGgeneV2: enhancements on the existing database , 2014, BMC Cancer.
[31] D. Bates,et al. Hallmarks of alternative splicing in cancer , 2014, Oncogene.
[32] H. Jim,et al. Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis , 2014, Supportive Care in Cancer.
[33] R. Bergan,et al. Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression , 2014, Oncotarget.
[34] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[35] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[36] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[37] D M Berney,et al. Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer , 2012, Prostate Cancer and Prostatic Diseases.
[38] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[39] John A. Calarco,et al. Emerging Roles of Alternative Pre-mRNA Splicing Regulation in Neuronal Development and Function , 2012, Front. Neurosci..
[40] S. Leung,et al. Type I gamma phosphatidylinositol phosphate kinase modulates invasion and proliferation and its expression correlates with poor prognosis in breast cancer , 2010, Breast Cancer Research.
[41] Francesco Piva,et al. SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans , 2009, Bioinform..
[42] J. Goodwin,et al. Effect of a dementia diagnosis on survival of older patients after a diagnosis of breast, colon, or prostate cancer: implications for cancer care. , 2008, Archives of internal medicine.
[43] C. Nelson,et al. Cognitive effects of hormone therapy in men with prostate cancer , 2008, Cancer.
[44] Yue Sun,et al. Type Iγ phosphatidylinositol phosphate kinase is required for EGF-stimulated directional cell migration , 2007, The Journal of cell biology.
[45] Boris Hadaschik,et al. The role of stress proteins in prostate cancer. , 2007, Current genomics.
[46] R. Bergan,et al. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer , 2006, Oncogene.
[47] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[48] G. Williams,et al. Staging of prostatic carcinoma with radionuclide bone scintigraphy and lymphography. , 1987, The British journal of radiology.